← back to search

Martín E. Stryjewski

Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno · US
Area of research
Infectious Diseases · Clinical Biochemistry
Research interest
Research interests include Antimicrobial Resistance in Staphylococcus, Bacterial Identification and Susceptibility Testing, Streptococcal Infections and Treatments, and Antibiotic Resistance in Bacteria.
h-index
45
citations
8,181
works
139
NIH funding
primary concept
Medicine
email

Recent publications

Clinical Characteristics and Outcomes of Bloodstream Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales in Argentina: A Subanalysis of the EMBARCAR Prospective Multicenter Cohort Study.
2026cited by 0position: contributordoi
Carbapenem-resistant Enterobacterales in solid organ transplant recipients
American Journal of Transplantation 2025cited by 6position: contributordoi
Carbapenem-Resistant Gram-Negative Bacilli Bacteremia in Argentina (EMBARCAR): Findings From a Prospective, Multicenter Cohort Study.
2025cited by 2position: contributordoi
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions.
2024cited by 65position: contributordoi
Infective Endocarditis After Transcatheter Versus Surgical Aortic Valve Replacement.
2024cited by 20position: contributordoi
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
2024cited by 12position: contributordoi
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens.
2024cited by 4position: contributordoi
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
2024cited by 4position: contributordoi
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.
2024cited by 3position: contributordoi
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study
The Lancet Microbe 2023cited by 281position: middledoi
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.
2023cited by 209position: contributordoi
Ceftobiprole for Treatment of Complicated <i>Staphylococcus aureus</i> Bacteremia
New England Journal of Medicine 2023cited by 95position: middledoi
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant <i>Acinetobacter baumannii</i> Among Patients From Different Global Regions
Clinical Infectious Diseases 2023cited by 88position: middledoi
Ceftobiprole for Treatment of Complicated &lt;i&gt;Staphylococcus aureus&lt;/i&gt; Bacteremia.
2023cited by 66position: contributordoi
Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000-2012).
2023cited by 49position: contributordoi
International Epidemiology of Carbapenemase-Producing Escherichia coli.
2023cited by 29position: contributordoi
Correction: Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000-2012).
2023cited by 3position: contributordoi
Shedding of infectious SARS-CoV-2 in two asymptomatic children.
2023cited by 0position: contributor
[Comparative analysis of clinical characteristics, evolution and mortality of hospitalized patients with COVID-19 during the first and second wave of the pandemic (ECCOVID Study)].
2023cited by 0position: contributor
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
2022cited by 261position: contributordoi
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.
2022cited by 50position: contributordoi
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.
2022cited by 24position: contributordoi
Saliva screening of health care workers for SARS-CoV-2 detection.
2022cited by 1position: contributordoi
Response.
2022cited by 0position: contributordoi
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
The Lancet Infectious Diseases 2021cited by 334position: middledoi
Infective Endocarditis in Patients on Chronic Hemodialysis.
2021cited by 45position: contributordoi
Characteristics of Patients Co-infected with Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus, Buenos Aires, Argentina, March-June 2020.
2021cited by 23position: contributordoi
Self-collected saliva for SARS-CoV-2 detection: A prospective study in the emergency room.
2021cited by 19position: contributordoi
Clinical characteristics and outcomes of hospitalized patients with SARS-CoV-2 infection in a Latin American country: Results from the ECCOVID multicenter prospective study.
2021cited by 13position: contributordoi
A 31-Year-Old Man With Seizures, Brain Lesion, and Lung Nodules.
2021cited by 3position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Robin Patel · Mayo Clinic4 papers (2022–2024)Pierre-Edouard Fournier · Laboratoire National de Référence4 papers (2021–2024)Peter Chen · Cedars-Sinai Medical Center4 papers (2022–2024)Mark Holodniy · Veterans Health Administration4 papers (2022–2024)Mahesh Parmar · Tata Memorial Hospital4 papers (2022–2024)Anna L Goodman · St. Thomas Hospital4 papers (2022–2024)José Muñóz · Hospital General Universitario Gregorio Marañón3 papers (2024–2024)David Gordon · National Health and Medical Research Council3 papers (2021–2023)David van Duin · University of North Carolina at Chapel Hill3 papers (2023–2025)María Virginia Villegas · Universidad El Bosque3 papers (2022–2023)José M. Munita · Universidad del Desarrollo3 papers (2022–2024)Jens Lundgren · Aalborg University3 papers (2022–2024)Ezequiel Cordova · Argerich Hospital3 papers (2024–2026)Samuel M. Brown · Association Clinique et Thérapeutique Infantile du Val de Marne3 papers (2022–2024)Jordi Carratala · Centro de Investigación Biomédica en Red de Salud Mental3 papers (2024–2024) · 3 papers (2023–2025)Sanjay Bhagani · Royal Free London NHS Foundation Trust2 papers (2022–2024)Blake Hanson · The University of Texas Health Science Center2 papers (2023–2024)Sara E. Cosgrove · University of Baltimore2 papers (2023–2023)Juan Ambrosioni · Centro de Investigación Biomédica en Red de Cáncer2 papers (2023–2023)